Clock Inhibitors

GSK-J4, a JMJD3 inhibitor, indirectly influences Clock by targeting the Jumonji domain-containing protein 3 (JMJD3). By inhibiting JMJD3, GSK-J4 modulates the epigenetic landscape, indirectly affecting Clock expression. The compound acts as an indirect inhibitor by disrupting the epigenetic regulation of Clock, thereby influencing circadian rhythm at the chromatin level.

Nobiletin, a flavonoid, indirectly modulates Clock by affecting the Nrf2/ARE signaling pathway. By activating Nrf2, Nobiletin influences the expression of Clock and its downstream targets. The compound acts as an indirect inhibitor by altering cellular redox status, thereby impacting Clock expression and circadian rhythm regulation through the Nrf2/ARE pathway.

CHIR-99021, a GSK-3β inhibitor, indirectly influences Clock by modulating the Wnt/β-catenin pathway. By inhibiting GSK-3β, CHIR-99021 activates Wnt signaling, indirectly impacting Clock expression and circadian rhythm regulation. The compound acts as an indirect inhibitor by influencing the Wnt/β-catenin pathway, a signaling cascade intricately linked to the regulation of Clock and circadian rhythms.

5-Aza-2'-deoxycytidine, a DNA methyltransferase inhibitor, indirectly modulates Clock by influencing DNA methylation patterns. By inhibiting DNA methyltransferases, it alters the epigenetic landscape, indirectly affecting Clock expression. The compound acts as an indirect inhibitor by disrupting DNA methylation, thereby influencing circadian rhythm regulation through epigenetic modifications.

PD98059, a MEK inhibitor, indirectly influences Clock by targeting the MAPK/ERK signaling pathway. By inhibiting MEK, PD98059 modulates downstream events, indirectly impacting Clock expression and circadian rhythm regulation. The compound acts as an indirect inhibitor by affecting the MAPK/ERK pathway, a signaling cascade involved in the regulation of Clock and circadian rhythms.

SRT1720, a SIRT1 activator, directly modulates Clock by activating the NAD-dependent deacetylase SIRT1. This activation influences the deacetylation of Clock, impacting circadian rhythm regulation at the post-translational level. The compound acts as a direct inhibitor by enhancing SIRT1 activity, leading to the modification of Clock and modulation of circadian rhythms.

Dorsomorphin, an AMPK inhibitor, indirectly influences Clock by modulating the AMPK signaling pathway. By inhibiting AMPK, Dorsomorphin alters downstream events, indirectly affecting Clock expression and circadian rhythm regulation. The compound acts as an indirect inhibitor by influencing the AMPK pathway, a key regulator of cellular energy status and circadian rhythms through interactions with Clock.

JIB-04, a Jumonji histone demethylase inhibitor, indirectly modulates Clock by targeting Jumonji histone demethylases. By inhibiting these enzymes, JIB-04 influences the epigenetic regulation of Clock, indirectly affecting its expression. The compound acts as an indirect inhibitor by disrupting histone demethylation processes, thereby impacting the epigenetic control of Clock and circadian rhythm regulation.

SGC-CBP30, a CBP/p300 bromodomain inhibitor, indirectly influences Clock by targeting the bromodomain-containing proteins CBP and p300. By inhibiting these proteins, SGC-CBP30 disrupts epigenetic processes, indirectly affecting Clock expression and circadian rhythm regulation. The compound acts as an indirect inhibitor by modulating the bromodomain-dependent epigenetic regulation of Clock and circadian rhythms.

SB431542, a TGF-β receptor inhibitor, indirectly modulates Clock by affecting the TGF-β signaling pathway. By inhibiting TGF-β receptors, SB431542 alters downstream events, indirectly influencing Clock expression and circadian rhythm regulation. The compound acts as an indirect inhibitor by disrupting the TGF-β signaling pathway, a regulatory mechanism intricately linked to the modulation of Clock and circadian rhythms.